麻豆传媒

Feature Channels: Biotech

Filters close
Go to Advanced Search
access_time Embargo lifts in 2 days
This news release is embargoed until 3-Apr-2025 2:00 PM EDT Released to reporters: 2-Apr-2025 7:55 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Apr-2025 2:00 PM EDT The 麻豆传媒 PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

麻豆传媒: Breakthrough in Anti-Aging Solutions: Supramolecular Bakuchiol in Ionic Liquid Enhances Efficacy and Minimizing Irritation
Released: 2-Apr-2025 11:05 AM EDT
Breakthrough in Anti-Aging Solutions: Supramolecular Bakuchiol in Ionic Liquid Enhances Efficacy and Minimizing Irritation
Chinese Academy of Sciences

A groundbreaking study published in Supramolecular Materials introduces a novel supramolecular solution of bakuchiol, a plant-derived retinol alternative, using an ionic liquid (IL) carrier. This innovation achieves a breakthrough in anti-aging by delivering both high efficacy and skin-friendly gentleness.

麻豆传媒: Researchers to Map the Genome of the Invasive European Green Crab
Released: 2-Apr-2025 8:00 AM EDT
Researchers to Map the Genome of the Invasive European Green Crab
Woods Hole Oceanographic Institution

With state funding, Washington Sea Grant will work with the Washington Department of Fish and Wildlife and the Woods Hole Oceanographic Institution to shed light on a highly invasive species

麻豆传媒: From Flavonoids to Stilbenoids: CRISPR Unlocks a New Path for Natural Resveratrol
Released: 2-Apr-2025 5:40 AM EDT
From Flavonoids to Stilbenoids: CRISPR Unlocks a New Path for Natural Resveratrol
Chinese Academy of Sciences

A recent study showcases the power of CRISPR gene editing to significantly boost the production of resveratrol, a plant-derived compound with numerous health benefits. Researchers successfully targeted a key gene in grape cells, redirecting the plant鈥檚 metabolic pathways to prioritize resveratrol production. As a result, engineered grape cells produced over four times more resveratrol than normal, providing a potential solution to the challenges of sourcing this valuable molecule. This innovative method could revolutionize the availability of resveratrol for use in supplements, medicines, and functional foods, and could also serve as a model for increasing the production of other beneficial plant compounds.

麻豆传媒: Stiffness Measurement Without Organoid Damage AIDS Drug Development for Fatty Liver Disease
Released: 2-Apr-2025 12:00 AM EDT
Stiffness Measurement Without Organoid Damage AIDS Drug Development for Fatty Liver Disease
National Research Council of Science and Technology

The research team led by Dr. Hyunwoo Kim and Dr. Myungae Bae at the Korea Research Institute of Chemical Technology (KRICT) has developed the nano-probe-based quantitative stiffness measurement technique for a non-alcoholic fatty liver disease (NAFLD) simulate artificial organoid model while minimizing tissue damage.

麻豆传媒: Van Andel Institute鈥檚 Dr. Hui Shen elected to the AIMBE College of Fellows
Released: 31-Mar-2025 7:40 PM EDT
Van Andel Institute鈥檚 Dr. Hui Shen elected to the AIMBE College of Fellows
Van Andel Institute

Van Andel Institute鈥檚 Hui Shen, Ph.D., has been elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows, a prestigious appointment that represents the top 2% of medical and biological engineers.

麻豆传媒: Brian Brown, PhD, Inducted Into AIMBE College of Fellows for Pioneering Contributions in Gene Therapy and Functional Genomics
Released: 31-Mar-2025 3:00 PM EDT
Brian Brown, PhD, Inducted Into AIMBE College of Fellows for Pioneering Contributions in Gene Therapy and Functional Genomics
Mount Sinai Health System

Brian Brown, PhD, Director of the Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai, has been elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE).

麻豆传媒: Experimental Blood Test Shown to Accurately Indicate Severity and Predict Potential Recovery from Spinal Cord Injury
Released: 31-Mar-2025 11:00 AM EDT
Experimental Blood Test Shown to Accurately Indicate Severity and Predict Potential Recovery from Spinal Cord Injury
Johns Hopkins Medicine

By analyzing DNA and proteins in the blood of people with and without acute spinal cord injuries (SCIs), researchers at the Johns Hopkins University School of Medicine have developed a novel blood test that has the potential to rapidly predict severity and likelihood of sensory and motor recovery within six months in a cost-effective manner.

麻豆传媒: New Method Creates 854x More Mitochondria, Offering Hope for Cartilage Regeneration
Released: 31-Mar-2025 6:10 AM EDT
New Method Creates 854x More Mitochondria, Offering Hope for Cartilage Regeneration
Chinese Academy of Sciences

Scientists have unveiled a revolutionary method for mass-producing high-quality human mitochondria, potentially transforming treatments for degenerative diseases. By refining stem cell culture conditions, researchers achieved an extraordinary 854-fold increase in mitochondrial production while significantly enhancing energy output.

Released: 28-Mar-2025 7:00 PM EDT
Meniscus Injuries May Soon Be Treated by Customizable Hydrogel
Perelman School of Medicine at the University of Pennsylvania

A new 3D printed customizable hydrogel performed well in preclinical trials with several different types of meniscal tears

麻豆传媒: Brain Channels 鈥楽topped in Time鈥 Reveal Chemical Flow That Enables Learning and Thinking
Released: 28-Mar-2025 6:45 PM EDT
Brain Channels 鈥楽topped in Time鈥 Reveal Chemical Flow That Enables Learning and Thinking
Johns Hopkins Medicine

A study led by Johns Hopkins Medicine researchers could advance the development of new drugs that block or open such signaling channels to treat conditions as varied as epilepsy and some intellectual disorders.

Released: 28-Mar-2025 5:50 PM EDT
MiRus Siegel鈩 TAVR: First EFS Cases
MiRus

MiRus is pleased to announce the launch of the US multi-center Early Feasibility Study of the Siegel鈩 8-Fr aortic transcatheter heart valve (THV).

   
麻豆传媒: FAMU-FSU College of Engineering Researchers Create Innovative Microparticles That Unlock New Insights Into Protein Degradation and Immune Cell Behavior
Released: 27-Mar-2025 7:50 PM EDT
FAMU-FSU College of Engineering Researchers Create Innovative Microparticles That Unlock New Insights Into Protein Degradation and Immune Cell Behavior
Florida State University

FAMU-FSU College of Engineering researchers have created a new method for studying protein degradation within immune cells that uses engineered microparticles to track and analyze degradation processes more effectively than traditional methods. The work, which was published in ACS Applied Materials & Interfaces, has important implications for treating diseases such as cancer, Alzheimer鈥檚 disease and autoimmune disorders.

Released: 27-Mar-2025 6:10 PM EDT
MD Anderson Research Highlights for March 27, 2025
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center鈥檚 Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson鈥檚 world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
麻豆传媒: Biobreeding Technology Enables Rapid Development of Golden Grass Carp Germplasm
Released: 27-Mar-2025 5:20 PM EDT
Biobreeding Technology Enables Rapid Development of Golden Grass Carp Germplasm
Chinese Academy of Sciences

This study achieved CRISPR/Cas9-mediated genome editing in grass carp (Ctenopharyngodon idella), China's most economically vital freshwater fish. Targeting the tyrb gene critical for pigmentation were performed. Mutations confirmed by sequencing caused a golden phenotype with melanophore reduction. Using multiple gRNAs enhanced mutation rates (88.9%) and triggered large DNA deletions.

Released: 27-Mar-2025 10:20 AM EDT
Engenheiros de manufatura da Mayo Clinic est茫o prestes a entregar novas bioterapias
Mayo Clinic

Engenheiros de manufatura est茫o na vanguarda de trazer novos medicamentos derivados de fontes humanas, como c茅lulas, sangue e genes, para os pacientes. Eles produzem o que muitas vezes s茫o bioterapias pioneiras do seu tipo para doen莽as que anteriormente tinham poucas ou nenhuma op莽茫o de tratamento.

   
Released: 27-Mar-2025 9:45 AM EDT
Mayo Clinic Manufacturing Engineers on the Cusp of Delivering New Biotherapies
Mayo Clinic

Manufacturing engineers are at the forefront of bringing new medicines derived from human sources such as cells, blood and genes to patients. They produce what are often first-of-their kind biotherapies for diseases that previously had few or no treatment options.

   
Released: 27-Mar-2025 9:15 AM EDT
Ingenieros de manufactura de Mayo Clinic est谩n a punto de entregar nuevas bioterapias
Mayo Clinic

JACKSONVILLE, Florida 鈥 Ingenieros de manufactura est谩n a la vanguardia de llevar nuevos medicamentos derivados de fuentes humanas, como c茅lulas, sangre y genes, a los pacientes. Ellos producen lo que a menudo son bioterapias pioneras de su tipo para enfermedades que anteriormente ten铆an pocas o ninguna opci贸n de tratamiento.

   


close
2.73379